BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23487343)

  • 1. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.
    Violi F; Ferro D
    Semin Thromb Hemost; 2013 Jun; 39(4):426-33. PubMed ID: 23487343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes.
    Basili S; Raparelli V; Violi F
    Eur J Intern Med; 2010 Apr; 21(2):62-4. PubMed ID: 20206871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding and thrombosis in cirrhotic patients: what really matters?
    Ferro D; Angelico F; Caldwell SH; Violi F
    Dig Liver Dis; 2012 Apr; 44(4):275-9. PubMed ID: 22119620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study.
    Violi F; Leo R; Basili S; Ferro D; Cordova C; Balsano F;
    Haematologica; 1994; 79(1):61-5. PubMed ID: 15378950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
    Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
    Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fibrinolytic Status in Liver Diseases.
    Leebeek FW; Rijken DC
    Semin Thromb Hemost; 2015 Jul; 41(5):474-80. PubMed ID: 26049070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coagulation and cirrhosis: new insight].
    Ditisheim S; Goossens N; Spahr L; Hadengue A
    Rev Med Suisse; 2012 Sep; 8(352):1652, 1654-6. PubMed ID: 22988724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfibrinolysis in liver disease.
    Ferro D; Celestini A; Violi F
    Clin Liver Dis; 2009 Feb; 13(1):21-31. PubMed ID: 19150306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy in liver diseases: complication or therapy?
    Bianchini M; De Pietri L; Villa E
    Dig Dis; 2014; 32(5):609-14. PubMed ID: 25034295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation disorders in liver disease.
    Amitrano L; Guardascione MA; Brancaccio V; Balzano A
    Semin Liver Dis; 2002 Feb; 22(1):83-96. PubMed ID: 11928081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood coagulation disorders in liver cirrhosis in relation to the degree of portal hypertension].
    Klingemann HG; Schmidt U; Brunswig D; Egbring R; Kaffarnik H
    Fortschr Med; 1980 Oct; 98(40):1561-66. PubMed ID: 6970156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coagulation disorders in cirrhosis].
    Téllez-Avila FI; Chávez-Tapia NC; Torre-Delgadillo A
    Rev Invest Clin; 2007; 59(2):153-60. PubMed ID: 17633804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ABNORMALITIES OF HEMOSTASIS IN PATIENTS WITH LIVER CIRRHOSIS].
    Majerović M; Boban A; Premužić M; Radić D; Knežević-Štromar I; Ladić A; Krznarić Ž; Rustemović N; Ostojić R
    Lijec Vjesn; 2016; 138(9-10):272-81. PubMed ID: 30148556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation studies in patients with cirrhosis of liver: bleeders vs non-bleeders.
    Rastogi P; Gupta SC; Bisht D
    Indian J Pathol Microbiol; 1990 Oct; 33(4):323-7. PubMed ID: 2132499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation abnormalities in the cirrhotic patient.
    Muciño-Bermejo J; Carrillo-Esper R; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2013; 12(5):713-24. PubMed ID: 24018489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
    Hu KQ; Yu AS; Tiyyagura L; Redeker AG; Reynolds TB
    Am J Gastroenterol; 2001 May; 96(5):1581-6. PubMed ID: 11374703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis.
    Amitrano L; Guardascione MA; Ames PR
    Clin Lab; 2007; 53(9-12):583-9. PubMed ID: 18257465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring blood coagulation in larger liver operations].
    Groh J; Welte M; Azad SC; Kratzer MA
    Infusionsther Transfusionsmed; 1993 Aug; 20(4):173-9. PubMed ID: 8400798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.